About US
Contact us
-
The 2015 edition of Chinese Pharmacopoeia to enhance the overall level of China's drug qualityThe 2015 edition of Chinese Pharmacopoeia was recently adopted at the plenary session of the Executive Committee of the Tenth Chinese Pharmacopoeia Commission. On June 5, 2015, China Food and Drug Adm2015/7/2
-
Drug Administration Law of the People's Republic of ChinaOrder of the President of the Peoples Republic of China (No. 45) The Drug Administration Law of the People’s Republic of China, revised at the 20th Meeting of the Standing Committee of the Ninth Nat2015/7/2
-
Bad news for AstraZeneca: FDA lays out roadmap for would-be Symbicort copycatsCourtesy of AstraZeneca The FDA has issued AstraZeneca's ($AZN) least favorite form of draft guidance--the kind that helps other drugmakers develop copies of a blockbuster seller. Regulato2015/7/2
-
Bayer, J&J aim to protect Xarelto's market lead with focus on clinical dataBayerand Johnson & Johnson ($JNJ) know that right now, there's an impression out there that rival drugEliquis--from Pfizer ($PFE) and Bristol-Myers Squibb ($BMY)--is superior to their next-gen clo2015/7/2
-
CFDA officially joins the Interim Management Committee of ICMRAUpon the approval of the State Council, China Food and Drug Administration (CFDA) officially joined the Interim Management Committee of the International Coalition of Medicines Regulatory Authorities2015/7/1
-
2015 Minister-level Seminar on Pharmaceutical Supervision and Management for Developing Countries held in BeijingOn June 24, 2015, the 2015 Minister-level Seminar on Pharmaceutical Supervision and Management for Developing Countries undertaken by China Food and Drug Administration (CFDA) was held in Beijing. Min2015/7/1
-
Allergan to close plant in Iceland, lay off 300Allergan ($AGN) ChairmanPaul Bisarohas been quick to cut what he sees as redundant operations and people to help pay for his aggressive buying. Now, he has set his sights on the company's ancestry, wi2015/7/1
-
Pharma to EU officials: We need 'contingency' supply plans in case of 'Grexit'Drugmakers are raising an alarm about shortages in Greece as the possibility of a "Grexit" looms. That "worst-case scenario" could put supplies in peril, the European Federation of Pharmaceutical Indu2015/7/1
-
Danny Glover signs up with Avanir to spotlight pseudobulbar affectActors cry and laugh on command, but people who have pseudobulbar affect (PBA) can't control their crying jags or laughing fits. That's the central idea of Nuedexta-makerAvanir's new PBA awareness eff2015/6/30
-
Bigger pharma may be scraping for good deals, but Horizon has plenty of options, analysts sayHorizon Pharma ($HZNP) isn't exactly the only specialty pharma company hunting for deals. Allergan ($AGN), Mallinckrodt ($MNK), Endo ($ENDP) and the ever-acquisitive Valeant ($VRX) have all been on sh2015/6/30